Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07789275Phase 4Recruiting
Phase 4, randomised, double-blind trial of remimazolam in intraoperative hypotension (IOH) (2 arms), sponsored by Beijing Tsinghua Changgung Hospital. Primary endpoint: Time-weighted average of mean arterial pressure below 65 mmHg during liver parenchymal transection. Started Sep 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07789275.